In order to explore the effect of NUTM2A-AS1 on the proliferation and invasion of breast cancer cell lines, we constructed a knockdown plasmid of NUTM2A-AS1 and successfully reduced the expression of NUTM2A-AS1 in breast cancer cells (Figure 2(a)). This evidence concerns the gene NUTM2A and breast carcinoma.